Volume 10, number 1
 PDF Downloads: 630

Prevalence of Sickle Cell Anemia and Thalassemia among Anemic Patients of Al-Noor Specialist Hospital, Makkah, KSA

Sickle Cell Anemia, Anemic Patients and Thalassemia H. Faidah1,2, M. Samy2 and A. A Tashkandi3

1Umm AL Qura University, Faculty of Medicine. 2Alnoor Specialist Hospital, Laboratory and Blood Bank Department 3National Guard Hospital, Emergency Department..

DOI : http://dx.doi.org/10.13005/bbra/1089

ABSTRACT: This study aimed to to determine the prevalence of Sickle cell diseases and trait and high hemoglobin (Hb) A2 b- thalassemia in the province of Makkah among patients of Al-Noor Specialist hospital, Makkah. Retrospective studying the results of 620 requested saudi patients (256 male and 364 female) suffer from Anemia for gel electrophoresis. Covering the period between 1 January 2012 to 30 December 2012 was presented. It was found a significant increase (P<0.05) in prevalence of anemia among females compared to males (1.42/1 ratio). The prevalence for Sickle cell anemia was (38.38%) which showed highly significant increase comparing with (P>0.01) ²-Thalassmia (5.32%) and Non A2 Hemoglobin (2.90%). ²-Thalassmia also, showed significant increase P<0.05) compared with Non A2 Hemoglobin. Hemoglobinopathies occurs frequently among our patients, with majority of cases having Sickle cells anaemia, and cases with heterozygous mutation (trait disease) was the predominant.

KEYWORDS: Sickle Cell Anemia; Anemic Patients; Thalassemia

Download this article as: 
Copy the following to cite this article:

H Faidah, Samy M, Tashkandi A. A. Prevalence of Sickle Cell Anemia and Thalassemia among Anemic Patients of Al-Noor Specialist Hospital, Makkah, KSA. Biosci Biotechnol Res Asia 2013;10(1)

Copy the following to cite this URL:

H Faidah, Samy M, Tashkandi A. A. Prevalence of Sickle Cell Anemia and Thalassemia among Anemic Patients of Al-Noor Specialist Hospital, Makkah, KSA. Biosci Biotechnol Res Asia 2013;10(1). Available from:https://www.biotech-asia.org/?p=9873

[ HTML Full Text]

Back to TOC